Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 to reflect the latest site version.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; a minor administrative update with no changes to study content or user-facing information.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision v3.4.1 removed and v3.4.2 added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedA new 'Show glossary' option appears, capitalization of several labels has updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the revision identifier changed from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check94 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.